Steve Schonfeld’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-12,500
Closed -$9.54M 2343
2025
Q3
$9.54M Buy
+12,500
New +$9.3M 0.05% 364
2025
Q2
Sell
-14,600
Closed -$12.1M 2320
2025
Q1
$12.1M Buy
+14,600
New +$12.1M 0.07% 270
2024
Q2
Sell
-700
Closed -$545K 2383
2024
Q1
$545K Buy
+700
New +$498K ﹤0.01% 1453
2023
Q3
Sell
-100,000
Closed -$5K 2060
2023
Q2
$5K Hold
100,000
﹤0.01% 1941
2023
Q1
$693K Buy
+100,000
New +$33.7M 0.01% 1076

Other funds holding LLY

Steve Schonfeld's LLY Position: Q2 2026 in Review

Steve Schonfeld increased its Eli Lilly (LLY) stake by 816% in Q2 2026, buying an estimated $219M and bringing the position to 240,327 shares worth $48.5M. The position accounts for 0.17% of the portfolio, ranked #96.

Steve Schonfeld first reported a position in LLY in Q4 2016 and has held it in 30 quarters since. The position peaked at $74.1M in Q2 2025. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Steve Schonfeld held 240,327 shares of Eli Lilly worth $48.5M as of Q2 2026.
  • Steve Schonfeld bought 214,090 Eli Lilly shares in Q2 2026, an estimated $219M.
  • Eli Lilly made up 0.17% of Steve Schonfeld's portfolio in Q2 2026, its #96 holding.
  • Steve Schonfeld first reported a position in Eli Lilly in Q4 2016 and has held it in 30 quarters since.
  • Steve Schonfeld's Eli Lilly position peaked at $74.1M in Q2 2025.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Schonfeld Strategic Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.